Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMETHYST trial of mifepristone added to methotrexate for tubal ectopic pregnancy
ISRCTN15446999Phase 3Recruiting
- Sponsor
- University of Aberdeen
- Start
- Apr 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mifepristone and methotrexate in Ectopic pregnancy (EP), sponsored by University of Aberdeen. Primary endpoint: Rate of surgery to treat tubal ectopic pregnancy. Started Apr 2026; status: recruiting.
02
Drugs
mifepristonemethotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on ISRCTN15446999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15446999.